Cargando…

Inflammatory Mediators in Obesity

Detalles Bibliográficos
Autores principales:	Kumar, Divya P., Koka, Saisudha, Li, Chao, Rajagopal, Senthilkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702839/ https://www.ncbi.nlm.nih.gov/pubmed/31485196 http://dx.doi.org/10.1155/2019/9481819

Ejemplares similares

Obesity: An overview on its current perspectives and treatment options
por: Nammi, Srinivas, et al.
Publicado: (2004)

High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
por: Singh, Gurinder Bir, et al.
Publicado: (2019)

Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene
por: Boini, Krishna M., et al.
Publicado: (2016)

Editorial: Regulatory action of calcium channels in pain pathway
por: Rajagopal, Senthilkumar, et al.
Publicado: (2022)

Azathioprine favourably influences the course of malaria
por: Bobbala, Diwakar, et al.
Publicado: (2009)

Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine—a possible prevention strategy for COVID-19?
por: Kukreja, Rakesh C., et al.
Publicado: (2022)

Nicotine instigates podocyte injury via NLRP3 inflammasomes activation
por: Singh, Gurinder Bir, et al.
Publicado: (2019)

Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia
por: Koka, Saisudha, et al.
Publicado: (2017)

Impact of a Yogic Breathing Technique on the Well-Being of Healthcare Professionals During the COVID-19 Pandemic
por: Kanchibhotla, Divya, et al.
Publicado: (2021)

Editorial: Regulatory Action of Calcium Channels in Pain Pathway
por: Rajagopal, Senthilkumar, et al.
Publicado: (2021)

Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H(2)S
por: Bala, Vanitha, et al.
Publicado: (2014)

Obesity, a Diet-Induced Inflammatory Disease
por: Lecube, Albert, et al.
Publicado: (2019)

Inflammatory Mediators of Angiogenesis
por: Szewczyk, Grzegorz, et al.
Publicado: (2013)

Mediators of Inflammation in Obesity and Its Comorbidities
por: Gualillo, Oreste
Publicado: (2010)

Inflammatory Mediators in Periodontal Pathogenesis
por: Huck, Olivier, et al.
Publicado: (2019)

Macrophage-Mediated Inflammatory Disorders
por: Jou, I-Ming, et al.
Publicado: (2013)

Inflammatory and Fibrotic Mediators in Renal Diseases
por: Rayego-Mateos, Sandra, et al.
Publicado: (2019)

Inflammatory and Immune-Mediated Cutaneous Diseases
por: Quaresma, Juarez A. S., et al.
Publicado: (2017)

Inflammatory markers and mediators in heart disease
por: Valdes, Ana M., et al.
Publicado: (2018)

Inflammatory Mediators in Autoimmunity and Systemic Autoimmune Diseases
por: Nakken, Britt, et al.
Publicado: (2015)

The Role of Mast Cells and Their Inflammatory Mediators in Immunity
por: Theoharides, Theoharis C.
Publicado: (2023)

Immune and Inflammatory Processes in Obesity, Insulin Resistance, Diabetes, and Related Cardiometabolic Complications
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

Current Research on Antioxidant, Anti-Inflammatory and Anti-Obesity Potential of Food Extracts
por: Rivero-Pino, Fernando, et al.
Publicado: (2023)

The Role of Inflammatory Mediators in Immune-to-Brain Communication during Health and Disease
por: Gomez-Nicola, Diego, et al.
Publicado: (2013)

Immune and Inflammatory-Mediated Disorders: From Bench to Bedside
por: Reale, Marcella, et al.
Publicado: (2018)

The importance of immunization in immune-mediated inflammatory disease cannot be overstated
por: Park, Sang Hyoung
Publicado: (2018)

Inflammatory mediators in polycystic ovary syndrome: the case of interleukin-18
Publicado: (2022)

Biomarker-based Inflammatory Score in Obese Patients with Resistant Hypertension
por: Rodrigues, Cibele Isaac Saad
Publicado: (2019)

Obesity Treatment – Is Pharmacotherapy the Answer?
por: Rangbulla, Aditya Kumar
Publicado: (2020)

Estrogen-Mediated Effects Underlie Gender Bias in Inflammatory Bowel Disease
por: De Simone, Veronica, et al.
Publicado: (2018)

ERβ as a mediator of estrogen signaling in inflammatory breast cancer
por: Nagandla, Harika, et al.
Publicado: (2023)

Improving obesity treatment through telemedicine: increasing access to bariatric surgery
por: Chao, Grace F., et al.
Publicado: (2021)

Emerging Role of Aldosterone in Mediating the Vicious Cycle of Obesity, Insulin Resistance and Metabolic Syndrome
por: Park, Sungha
Publicado: (2018)

Editorial for Special Issue “Advances in the Pathogenesis and Treatment of Immune-Mediated Inflammatory Diseases”
por: van Hamburg, Jan Piet, et al.
Publicado: (2022)

Comparative effect of horse gram and black gram on inflammatory mediators and antioxidant status
por: Rajagopal, Vrinda, et al.
Publicado: (2016)

Cardiac cytokine therapy? Relevance of targeting inflammatory mediators to combat cardiac arrhythmogenic remodeling
por: Hiram, Roddy
Publicado: (2021)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

Evaluating the Correlation of Bariatric Surgery and the Prevalence of Cancers in Obese Patients: A Study of the National Inpatient Sample (NIS) Database
por: Desai, Devashish, et al.
Publicado: (2022)

Emerging Roles of Blood-Borne Intact and Respiring Mitochondria as Bidirectional Mediators of Pro- and Anti-Inflammatory Processes
por: Esch, Tobias, et al.
Publicado: (2020)

Obesity, Insulin Resistance, and Asthma
por: Allinson, James P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fkt5g82lano1arv697p7tdke5